CHARIOTMS_CMYK_postiive.jpg

ChariotMS is a clinical trial to investigate whether  Cladribine (MAVENCLAD®) - an established MS treatment,  can preserve upper limb function in people who  have largely lost the ability to walk  (EDSS 6.5-8.5).

 

This is affects some 44% of all  people with MS in the UK

ChariotMS is a groundbreaking trial:

It's the the first trial for wheelchair users  who are usually excluded from trials and  so have few licenced treatments.

It's  the first uk Clinical Trial with no upper age limit.

THE CHARIOT MS TEAM
THE CHARIOT MS CLINICAL TRIAL
CHARIOT MS CLINICAL TRIAL HUBS
 
Belfast
Birmingham
Brighton & Sussex
Bristol
Cardif
Edinburgh
Glasgow
Leeds
London
Liverpool
Luton
Plymouth
Salford
Sheffield
Swansea
 
CHARIOTMS RESEARCH & PUBLICATIONS
VIDEO GALLERY
CHARIOTMS SPONSORS
MORRIS - SADY TRUST